The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Molecular mechanisms and clinical applications of angiogenesis
Open accessAbstract
Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“This disparity is, in part, attributed to VEGF-independent nonangiogenic mechanisms of vascularization (such as vessel co-option) that are exploited by cancer cells at the early stages of metastasis formation6,9,55,56”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
In the citing paper
“Several cellular and molecular mechanisms of escape from antiangiogenic therapies have been postulated and investigated, including activation of alternative angiogenic pathways, recruitment of proangiogenic myeloid cells, increased pericyte cell coverage of tumour blood vessels, increased tumour cell invasion, and alternative modes of vessel recruitment7,9,80”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Tumour vessels become abnormal in almost all aspects of their structure and functio”
BackgroundSelf-citationAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Self-citationIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,551
Self-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Aberrant FGF signalling promotes tumour angiogenesis and mediates the escape of tumour vascularization from VEGF- or epidermal growth factor receptor (EGFR)-inhibitor treatmen”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citationHypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,021
Okkenhaug, K., Graupera, M., & Vanhaesebroeck, B. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0716 · Cited by 267
Feng, Q., Zhang, C., Lum, D. H., Druso, J. E., Blank, B. S., Wilson, K. F., Welm, A. L., Antonyak, M. A., & Cerione, R. A. (2017) · Nature Communications · doi:10.1038/ncomms14450 · Cited by 267
Integrating perfusable vascular networks with a three-dimensional tissue in a microfluidic device
Nashimoto, Y., Hayashi, T., Kunita, I., Nakamasu, A., Torisawa, Y.-S., Nakayama, M., Takigawa-Imamura, H., Kotera, H., Nishiyama, K., Miura, T., et al. (2017) · Integrative Biology · doi:10.1039/c7ib00024c · Cited by 266
Bai, L., Du, Z., Du, J., Yao, W., Zhang, J., Weng, Z., Liu, S., Zhao, Y., Liu, Y., Zhang, X., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.010 · Cited by 265
Medina-Leyte, D. J., Domínguez‐Pérez, M., Mercado, I., Villarreal-Molina, M. T., & Jacobo‐Albavera, L. (2020) · Applied Sciences · doi:10.3390/app10030938 · Cited by 265
Griveau, A., Seano, G., Shelton, S. J., Kupp, R., Jahangiri, A., Obernier, K., Krishnan, S., Lindberg, O. R., Yuen, T. J., Tien, A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.020 · Cited by 264
Self-citationTargeting galectin-driven regulatory circuits in cancer and fibrosis
Mariño, K. V., Cagnoni, A. J., Croci, D. O., & Rabinovich, G. A. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00636-2 · Cited by 266
Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment
Madu, C. O., Wang, S. Y., Madu, C. O., & Lu, Y. W. (2020) · Journal of Cancer · doi:10.7150/jca.44313 · Cited by 261
Liu, C., Ge, H., Liu, B.-H., Dong, R., Shan, K. Y., Chen, X., Yao, M.-D., Li, X., Yao, J., Zhou, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814874116 · Cited by 260
Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis
Palikuqi, B., Nguyen, D.-H. T., Li, G., Schreiner, R., Pellegata, A. F., Liu, Y., Redmond, D., Geng, F., Lin, Y., Gómez-Salinero, J. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2712-z · Cited by 259
Rahbari, N. N., Kedrin, D., Incio, J., Liu, H., Ho, W. W., Nia, H. T., Edrich, C. M., Jung, K., Daubriac, J., Chen, I., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5219 · Cited by 258
Self-citationTumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Plate, K. H., Scholz, A., & Dumont, D. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1066-5 · Cited by 257
Bae, H., Puranik, A. S., Gauvin, R., Edalat, F., Carrillo‐Conde, B., Peppas, N. A., & Khademhosseini, A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003688 · Cited by 257
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256
Endothelial PFKFB3 Plays a Critical Role in Angiogenesis
Xu, Y., An, X., Guo, X., Habtetsion, T. G., Wang, Y., Xu, X., Kandala, S., Li, Q., Li, H., Zhang, C., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303041 · Cited by 256
VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
Giacca, M., & Zacchigna, S. (2012) · Gene Therapy · doi:10.1038/gt.2012.17 · Cited by 255
Angiogenesis in the Infarcted Myocardium
Cochain, C., Channon, K. M., & Silvestre, J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4849 · Cited by 254
Senovilla, L., Vacchelli, E., Galon, J., Adjemian, S., Eggermont, A. M. M., Fridman, W. H., Sautès‐Fridman, C., Ma, Y., Tartour, É., Zitvogel, L., et al. (2012) · OncoImmunology · doi:10.4161/onci.22009 · Cited by 254
Microfluidic Models of Vascular Functions
Wong, K. H. K., Chan, J. M., Kamm, R. D., & Tien, J. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150052 · Cited by 254
Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2
Choi, H.-J., Zhang, H., Park, H., Choi, K.-S., Lee, H., Agrawal, V., Kim, Y., & Kwon, Y. (2015) · Nature Communications · doi:10.1038/ncomms7943 · Cited by 252
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
Emblem, K. E., Mouridsen, K., Bjørnerud, A., Farrar, C. T., Jennings, D. L., Borra, R., Wen, P. Y., Ivy, P. S., Batchelor, T. T., Rosen, B. R., et al. (2013) · Nature Medicine · doi:10.1038/nm.3289 · Cited by 251
Self-citationExosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis
Ribeiro‐Rodrigues, T., Laundos, T. L., Carvalho, R., Batista-Almeida, D., Pereira, R. V., Coelho‐Santos, V., Silva, A. P., Fernandes, R., Zuzarte, M., Enguita, F. J., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx118 · Cited by 251
The influence of platelet-derived products on angiogenesis and tissue repair: a concise update
Martínez, C., Smith, P. C., & Palma, V. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00290 · Cited by 250
Exploiting innate immunity for cancer immunotherapy
Yi, M., Li, T., Niu, M., Mei, Q., Zhao, B., Chu, Q., Dai, Z., & Wu, K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01885-w · Cited by 250
Tumor microenvironment components: Allies of cancer progression
Franco, P. I. R., Rodrigues, A. P., de Menezes, L. B., & Miguel, M. P. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152729 · Cited by 250
Effective bioprinting resolution in tissue model fabrication
Miri, A. K., Mirzaee, I., Hassan, S., Oskui, S. M., Nieto, D., Khademhosseini, A., & Zhang, Y. S. (2019) · Lab on a Chip · doi:10.1039/c8lc01037d · Cited by 248
The neurovascular link in health and disease: molecular mechanisms and therapeutic implications
Quaegebeur, A., Lange, C., & Carmeliet, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.013 · Cited by 247
Self-citationCancer immunotherapy via targeted TGF-β signalling blockade in TH cells
Li, S., Liu, M., Do, M. H., Chou, C., Stamatiades, E. G., Nixon, B. G., Shi, W., Zhang, X., Li, P., Gao, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2850-3 · Cited by 247
PlGF: A Multitasking Cytokine with Disease-Restricted ActivityPreprint
Dewerchin, M. A., & Carmeliet, P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011056 · Cited by 247
Self-citationInflammation and oxidative stress in angiogenesis and vascular disease
Kim, Y.-W., West, X. Z., & Byzova, T. V. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1007-3 · Cited by 246
Vasculogenic mimicry in small cell lung cancer
Williamson, S. C., Metcalf, R. L., Trapani, F., Mohan, S., Antonello, J., Abbott, B., Leong, H. S., Chester, C., Simms, N., Polański, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms13322 · Cited by 246
Balakrishnan, S., Bhat, F. A., Singh, P., Mukherjee, S., Perumal, E., Das, S., Patra, C. R., & Arunakaran, J. (2016) · Cell Proliferation · doi:10.1111/cpr.12296 · Cited by 244
VEGF signaling: Role in angiogenesis and beyond
Shaw, P., Dwivedi, S. K. D., Bhattacharya, R., Mukherjee, P., & Rao, G. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189079 · Cited by 244
Manegold, C., Dingemans, A. C., Gray, J. E., Nakagawa, K., Nicolson, M. C., Peters, S., Reck, M., Wu, Y.-L. L. C., Brustugun, O. T., Crinò, L., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.10.003 · Cited by 243
FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature
Sabine, A., Bovay, E., Demir, C. S., Kimura, W., Jaquet, M., Agalarov, Y., Zangger, N., Scallan, J. P., Graber, W. A., Gulpinar, E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80454 · Cited by 241
Complexation-induced resolution enhancement of 3D-printed hydrogel constructs
Gong, J., Schuurmans, C. C. L., van Genderen, A. M., Cao, X., Li, W., Cheng, F., He, J. J., López, A., Huerta, V., Manríquez, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14997-4 · Cited by 240
Li, L., Feng, X., Wei, T., Wang, Y., Wang, Y., Wang, Z., Tang, D., Luo, Y., & Xiong, Z. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1136-x · Cited by 237
Lu‐Emerson, C., Snuderl, M., Kirkpatrick, N. D., Goveia, J., Davidson, C. J., Huang, Y., Riedemann, L., Taylor, J. M., Ivy, P. S., Duda, D. G., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not082 · Cited by 235
Self-citationQuantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats
Napel, S. A., Mu, W., Jardim‐Perassi, B. V., Aerts, H. J. W. L., & Gillies, R. J. (2018) · Cancer · doi:10.1002/cncr.31630 · Cited by 235
The role IL-1 in tumor-mediated angiogenesis
Voronov, E., Carmi, Y., & Apte, R. N. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00114 · Cited by 233
Cao, Z., Bao, M., Miele, L., Sarkar, F. H., Wang, Z. P., & Zhou, Q. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.148 · Cited by 231
Early Loss of Pericytes and Perivascular Stromal Cell-Induced Scar Formation after Stroke
Fernández‐Klett, F., Potas, J. R., Hilpert, D., Blazej, K., Radke, J., Huck, J. H. J., Engel, O., Stenzel, W., Genové, G., & Priller, J. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.187 · Cited by 231
Integrin β1 controls VE-cadherin localization and blood vessel stability
Yamamoto, H., Ehling, M., Kato, K., Kanai, K., van Lessen, M., Frye, M., Zeuschner, D., Nakayama, M., Vestweber, D., & Adams, R. H. (2015) · Nature Communications · doi:10.1038/ncomms7429 · Cited by 229
Targeting BMP signalling in cardiovascular disease and anaemia
Morrell, N. W., Bloch, D. B., ten Dijke, P., Goumans, M., Hata, A., Smith, J., Yu, P. B., & Bloch, K. D. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.156 · Cited by 229
Qiu, S., Xie, L., Chen, L., Gu, C., Xia, Y., Lv, J., Xuan, Z., Fang, L., Yang, J., Zhang, L., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02499-8 · Cited by 228
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Cao, Z., Ding, B., Guo, P., Lee, S. B., Butler, J. M., Casey, S. C., Simons, M., Tam, W., Felsher, D. W., Shido, K., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.005 · Cited by 227
Forty-Year Journey of Angiogenesis Translational Research
Cao, Y., Arbiser, J. L., D’Amato, R. J., D'Amore, P. A., Ingber, D. E., Kerbel, R. S., Klagsbrun, M., Lim, S., Moses, M. A., Zetter, B. R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003149 · Cited by 226
Molecular Mechanisms of Tumor Angiogenesis
Ziyad, S., & Iruela‐Arispe, M. L. (2011) · Genes & Cancer · doi:10.1177/1947601911432334 · Cited by 225
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor
Li, D., March, M., Gutiérrez-Uzquiza, Á., Kao, C., Seiler, C., Pinto, E. M., Matsuoka, L. S., Battig, M. R., Bhoj, E. J. K., Wenger, T. L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0479-2 · Cited by 225
Weissleder, R., & Nahrendorf, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508524112 · Cited by 224
Incio, J., Ligibel, J. A., McManus, D. T., Suboj, P., Jung, K., Kawaguchi, K., Pinter, M., Babykutty, S., Chin, S. M., Vardam, T. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0945 · Cited by 222
Self-citationClinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Wind, S., Schmid, U., Freiwald, M., Marzin, K., Lotz, R. R. H., Ebner, T., Stopfer, P., & Dallinger, C. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00766-0 · Cited by 222
Clark, A. Y., Martin, K. E., García, J. R., Johnson, C. T., Theriault, H. S., Han, W. M., Zhou, D. W., Botchwey, E. A., & García, A. J. (2020) · Nature Communications · doi:10.1038/s41467-019-14000-9 · Cited by 222
Angiogenic Properties of Human Dental Pulp Stem Cells
Bronckaers, A., Hilkens, P., Fanton, Y., Struys, T., Gervois, P., Politis, C., Martens, W., & Lambrichts, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071104 · Cited by 221
Adipose tissue angiogenesis: Impact on obesity and type-2 diabetes
Corvera, S., & Gealekman, O. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.003 · Cited by 222
Hydrogen sulfide in cancer: Friend or foe?
Wu, D., Si, W., Wang, M.-J., Lv, S., Ji, A., & Li, Y. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.08.004 · Cited by 219
Advanced research on vasculogenic mimicry in cancer
Qiao, L., Liang, N., Zhang, J., Xie, J., Liu, F., Xu, D., Yu, X., & Tian, Y. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12496 · Cited by 218
Single-cell atlas of the human brain vasculature across development, adulthood and disease
Wälchli, T., Ghobrial, M., Schwab, M., Takada, S., Zhong, H., Suntharalingham, S., Vetiska, S., Rodríguez, D. G., Wu, R., Rehrauer, H., et al. (2024) · Nature · doi:10.1038/s41586-024-07493-y · Cited by 217
Self-citationCD146 is a coreceptor for VEGFR-2 in tumor angiogenesis
Jiang, T.-X., Zhuang, J., Duan, H., Luo, Y., Zeng, Q., Fan, K., Yan, H., Lü, D., Ye, Z., Hao, J., et al. (2012) · Blood · doi:10.1182/blood-2012-01-406108 · Cited by 216
Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction
Shan, K., Jiang, Q. L., Wang, X. Q., Wang, Y. N. Z., Yang, H., Yao, M. D., Liu, C., Li, X., Yao, J., Liu, B., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.145 · Cited by 216
Molecular genetics and targeted therapy of WNT-related human diseases (Review)
Katoh, M., & Katoh, M. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3071 · Cited by 216
Targeting the tumour vasculature: from vessel destruction to promotion
Guelfi, S., Hodivala‐Dilke, K., & Bergers, G. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00736-0 · Cited by 216
Bridgeman, V. L., Vermeulen, P. B., Foo, S., Bilecz, A., Daley, F., Kostaras, E., Nathan, M. R., Wan, E., Frentzas, S., Schweiger, T., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4845 · Cited by 214
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
Palazón, A., Aragonés, J., Morales-Kastresana, A., de Landázuri, M. O., & Melero, I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1591 · Cited by 214
Vascularization in Tissue Engineering: Angiogenesis versus Inosculation
Laschke, M. W., & Menger, M. D. (2012) · European Surgical Research · doi:10.1159/000336876 · Cited by 214
White matter degeneration in vascular and other ageing‐related dementias
Hase, Y., Horsburgh, K. J., Ihara, M., & Kalaria, R. N. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14271 · Cited by 214
The Neuropilin 1 Cytoplasmic Domain Is Required for VEGF-A-Dependent Arteriogenesis
Lanahan, A. A., Zhang, X., Fantin, A., Zhuang, Z. W., Rivera-Molina, F. E., Speichinger, K. R., Prahst, C., Zhang, J., Wang, Y., Davis, G. E., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.019 · Cited by 213
Chen, Y., Huang, Y., Reiberger, T., Duyverman, A. M. M. J., Huang, P., Samuel, R., Hiddingh, L., Roberge, S., Koppel, C., Lauwers, G. Y., et al. (2013) · Hepatology · doi:10.1002/hep.26790 · Cited by 212
Self-citationThe Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy
B, J. R. V. B., Nowak-Sliwinska, P. M., Huijbers, E. J. M., Thijssen, V. L., & Griffioen, A. W. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010215 · Cited by 211
Expert Consensus Document on Pulmonary Metastasectomy
Handy, J. R., Bremner, R. M., Crocenzi, T. S., Detterbeck, F. C., Fernando, H. C., Fidias, P. M., Firestone, S., Johnstone, C. A., Lanuti, M. D., Litle, V. R., et al. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.10.028 · Cited by 211
Ricard, N., Tu, L., Le Hiress, M., Huertas, A., Phan, C., Thuillet, R., Sattler, C., Fadel, E., Seferian, A., Montani, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007469 · Cited by 208
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies
Li, W., Croce, K., Steensma, D. P., McDermott, D. F., Ben‐Yehuda, O., & Moslehi, J. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.025 · Cited by 208
YB-1: oncoprotein, prognostic marker and therapeutic target?
Lasham, A., Print, C. G., Woolley, A. G., Dunn, S. E., & Braithwaite, A. W. (2012) · Biochemical Journal · doi:10.1042/bj20121323 · Cited by 206
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
Pisarsky, L., Bill, R., Fagiani, E., Dimeloe, S., Goosen, R., Hagmann, J., Hess, C., & Christofori, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.028 · Cited by 206
Drug and cell delivery for cardiac regeneration
Hastings, C. L., Roche, E. T., Ruiz‐Hernández, E., Schenke‐Layland, K., Walsh, C. J., & Duffy, G. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.006 · Cited by 205
Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy
Gacche, R. N., & Meshram, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.05.002 · Cited by 203
Goveia, J., Stapor, P. C., & Carmeliet, P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404156 · Cited by 203
Self-citationVrijsen, K. R., Maring, J. A., Chamuleau, S. A. J., Verhage, V., Mol, E. A., Deddens, J. C., Metz, C. H. G., Lodder, K., van Eeuwijk, E. C. M., van Dommelen, S. M., et al. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600308 · Cited by 203
CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties
Wakabayashi, T., Naito, H., Suehiro, J., Lin, Y., Kawaji, H., Iba, T., Kouno, T., Ishikawa-Kato, S., Furuno, M., Takara, K., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.01.010 · Cited by 203
Lang, H., Hu, G., Zhang, B., Kuang, W., Chen, Y., Wu, L., & Xu, G. (2017) · Oncology Reports · doi:10.3892/or.2017.5742 · Cited by 202
Al-Abd, A. M., Alamoudi, A. J., Abdel‐Naim, A. B., Neamatallah, T., & Ashour, O. M. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.06.006 · Cited by 202
Kienast, Y., Klein, C., Scheuer, W., Raemsch, R., Lorenzon, E., Bernicke, D., Herting, F., Yu, S., The, H. H., Martarello, L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0081 · Cited by 201
Kikuchi, R., Nakamura, K., MacLauchlan, S., Ngo, D. T. M., Shimizu, I., Fuster, J. J., Katanasaka, Y., Yoshida, S., Qiu, Y., Yamaguchi, T. P., et al. (2014) · Nature Medicine · doi:10.1038/nm.3703 · Cited by 201
The Role of MicroRNAs in Biological Processes
Tüfekçi, K. U., Meuwissen, R. L. J., & Genç, Ş. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-748-8_2 · Cited by 201
Brain metastases: pathobiology and emerging targeted therapies
Preusser, M., Capper, D., Ilhan‐Mutlu, A., Berghoff, A. S., Birner, P., Bartsch, R., Marosi, C., Zielinski, C. C., Mehta, M. P., Winkler, F., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0933-9 · Cited by 199
Therapeutic Angiogenesis for Treating Cardiovascular Diseases
Deveza, L. R., Choi, J. H.-K., & Yang, F. (2012) · Theranostics · doi:10.7150/thno.4419 · Cited by 198
Signalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration
Gilbert, R. W. D., Vickaryous, M. K., & Viloria‐Petit, A. (2016) · Journal of Developmental Biology · doi:10.3390/jdb4020021 · Cited by 198
Delgado-Martín, B., & Medina, M. Á. (2020) · Advanced Science · doi:10.1002/advs.201902971 · Cited by 198
Role and regulation of autophagy in cancer
Rakesh, R., Dharshini, L. C. P., Sakthivel, K. M., & Rasmi, R. R. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166400 · Cited by 198
Targeting ATR in DNA damage response and cancer therapeutics
Fokas, E., Prevo, R., Hammond, E. M., Brunner, T. B., McKenna, W. G., & Muschel, R. J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.002 · Cited by 197
Farnsworth, R. H., Lackmann, M., Achen, M. G., & Stacker, S. A. (2013) · Oncogene · doi:10.1038/onc.2013.304 · Cited by 197
Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
Lee, J. A., Uhlik, M. T., Moxham, C. M., Tomandl, D., & Sall, D. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201649s · Cited by 197
Cellular and molecular mechanisms in liver fibrogenesis
Novo, E., Cannito, S., Paternostro, C., Bocca, C., Miglietta, A., & Parola, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.02.015 · Cited by 194
Current and future trends in photoacoustic breast imaging
Manohar, S., & Dantuma, M. (2019) · Photoacoustics · doi:10.1016/j.pacs.2019.04.004 · Cited by 193
Angiogenesis in Tissue Engineering: As Nature Intended?
Mastrullo, V., Cathery, W., Velliou, E. G., Madeddu, P. R., & Campagnolo, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00188 · Cited by 193
TGF-β suppresses type 2 immunity to cancer
Liu, M., Kuo, F., Capistrano, K. J., Kang, D., Nixon, B. G., Shi, W., Chou, C., Do, M. H., Stamatiades, E. G., Gao, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2836-1 · Cited by 193
Intussusceptive Angiogenesis: A Biologically Relevant Form of Angiogenesis
Spiegelaere, W. D., Casteleyn, C. R., Broeck, W. V. D., Plendl, J., Bahramsoltani, M., Simoens, P., Djonov, V., & Cornillie, P. (2012) · Journal of Vascular Research · doi:10.1159/000338278 · Cited by 192
Kangsamaksin, T., Chaithongyot, S., Wootthichairangsan, C., Hanchaina, R., Tangshewinsirikul, C., & Svasti, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189628 · Cited by 193
Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment
Bourhis, M., Palle, J., Galy–Fauroux, I., & Terme, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616837 · Cited by 192
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carmeliet, Peter
- Jain, Rakesh K.
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 298-307
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4049445
- OpenAlex
- W1992112921
- Semantic Scholar
- cc1723f25e863386b91340ea03cd76a22de359ae
- Cited by
- 5,467
- References
- 100
- Citations by year
- 2026: 238 · 2025: 316 · 2024: 308 · 2023: 364 · 2022: 393 · 2021: 442 · 2020: 399 · 2019: 399 · 2018: 384 · 2017: 454 · 2016: 369 · 2015: 375 · 2014: 326 · 2013: 342 · 2012: 284
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01CA085140, P01CA080124, R01CA126642, R01CA163815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, angiogenesis inhibitors, vascular endothelial growth factor, VEGF inhibitors, drug resistance, molecular targets, cancer, eye diseases, blood vessel development
- MeSH terms
- Animals, Blood Vessels, Fibroblast Growth Factors, Humans, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vesicular Transport Proteins, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
